TW200607516A - Anti-angiogenic compositions containing beeswax - Google Patents
Anti-angiogenic compositions containing beeswaxInfo
- Publication number
- TW200607516A TW200607516A TW094124964A TW94124964A TW200607516A TW 200607516 A TW200607516 A TW 200607516A TW 094124964 A TW094124964 A TW 094124964A TW 94124964 A TW94124964 A TW 94124964A TW 200607516 A TW200607516 A TW 200607516A
- Authority
- TW
- Taiwan
- Prior art keywords
- extract
- compositions containing
- beeswax
- angiogenic compositions
- relates
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/60—Fish, e.g. seahorses; Fish eggs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
- A61K35/644—Beeswax; Propolis; Royal jelly; Honey
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Insects & Arthropods (AREA)
- Marine Sciences & Fisheries (AREA)
- Zoology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Heart & Thoracic Surgery (AREA)
- Animal Husbandry (AREA)
- Rheumatology (AREA)
- Mycology (AREA)
- Cardiology (AREA)
- Microbiology (AREA)
- Pain & Pain Management (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Vascular Medicine (AREA)
- Ophthalmology & Optometry (AREA)
- Botany (AREA)
- Urology & Nephrology (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to compositions comprising synergistically effective amounts of an anti-angiogenic extract and beeswax. The invention relates particularly to compositions containing an extract from shark meat or an extract from mussel meat, optionally including a mushroom extract, together with beeswax. The invention also relates to a method of treating or preventing diseases or disorders where it is desirable to inhibit angiogenesis using a composition of the invention.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NZ53426604 | 2004-07-22 |
Publications (2)
Publication Number | Publication Date |
---|---|
TW200607516A true TW200607516A (en) | 2006-03-01 |
TWI369989B TWI369989B (en) | 2012-08-11 |
Family
ID=35785496
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW094124964A TWI369989B (en) | 2004-07-22 | 2005-07-22 | Anti-angiogenic compositions containing beeswax |
Country Status (5)
Country | Link |
---|---|
JP (1) | JP2008507511A (en) |
KR (1) | KR20070047775A (en) |
CN (1) | CN101027068A (en) |
TW (1) | TWI369989B (en) |
WO (1) | WO2006009477A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008303199A (en) * | 2007-06-11 | 2008-12-18 | Heimat Ltd | Anti-neovascularization composition containing lipid extract of grifola frondosa and genistein |
US8279355B2 (en) * | 2009-09-25 | 2012-10-02 | Intel Corporation | Method and apparatus to support multi-channel reception |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH07308169A (en) * | 1994-05-16 | 1995-11-28 | Haputo Internatl:Kk | Admixture for processed food |
TW425285B (en) * | 1996-06-10 | 2001-03-11 | Viva America Marketing Inc | Fish oil and garlic nutritive supplement |
US5955102A (en) * | 1998-09-04 | 1999-09-21 | Amway Corporation | Softgel capsule containing DHA and antioxidants |
CN1245991C (en) * | 2000-12-20 | 2006-03-22 | 工业研究有限公司 | Shark meat extract |
RO119121B1 (en) * | 2002-01-29 | 2004-04-30 | Dana Mihaela Mihele | Pharmaceutical preparation containing oil extracted from the shark liver, having antiinflammatory and healing up properties |
JP4681801B2 (en) * | 2002-05-15 | 2011-05-11 | ビーエイチエヌ株式会社 | Angiogenesis inhibitor and method for producing the same |
JP4826696B2 (en) * | 2003-04-07 | 2011-11-30 | ビーエイチエヌ株式会社 | Angiogenesis inhibitors |
JP4506079B2 (en) * | 2002-12-18 | 2010-07-21 | ビーエイチエヌ株式会社 | Angiogenesis inhibitor |
JP4623999B2 (en) * | 2004-05-07 | 2011-02-02 | 丸善製薬株式会社 | Aldose reductase activity inhibitor, preventive / therapeutic agent for diabetic complications, and food and drink for the prevention / treatment of diabetic complications |
-
2005
- 2005-07-21 WO PCT/NZ2005/000179 patent/WO2006009477A1/en active Application Filing
- 2005-07-21 KR KR1020077002944A patent/KR20070047775A/en not_active Application Discontinuation
- 2005-07-21 CN CNA2005800247573A patent/CN101027068A/en active Pending
- 2005-07-21 JP JP2007522462A patent/JP2008507511A/en active Pending
- 2005-07-22 TW TW094124964A patent/TWI369989B/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CN101027068A (en) | 2007-08-29 |
TWI369989B (en) | 2012-08-11 |
WO2006009477A1 (en) | 2006-01-26 |
JP2008507511A (en) | 2008-03-13 |
KR20070047775A (en) | 2007-05-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2007022344A3 (en) | Methods and compositions for the preventioin and treatment of kidney disease | |
WO2006024018A3 (en) | Compositions for treating nociceptive pain | |
ZA200703002B (en) | Preparation and use of biphenyl-4-yl-carbonylamino acid derivatives for the treatment of obesity | |
WO2006044505A3 (en) | Compounds for nonsense suppression, and methods for their use | |
UA90668C2 (en) | Composition for the treatment of chronic venous insufficiencies comprising an extract of red vine leaves and an anti-inflammatory agent | |
WO2005117846A3 (en) | Ice inhibitors for the treatment of autoinflammatory diseases | |
WO2007121188A3 (en) | Compositions and methods of using r(+) pramipexole | |
SA519410204B1 (en) | S1PR4-Targeting Composition for Preventing or Treating Non-Alcoholic Steatohepatitis | |
HN2006000971A (en) | METHODS TO PREPARE COMPOSITIONS OR DOSAGE FORMS THAT INCLUDE A GRP119 AGONIST THAT HAS THE EFFECT OF A GLP-1 SECRETAGOG | |
WO2007038610A3 (en) | Use of natural products for treatment of neurological disorders | |
WO2005105107A3 (en) | Hormone treatment of multiple sclerosis | |
WO2009125964A3 (en) | Composition comprising polysaccharide extracted from panax ginseng preventing and treating liver diseases | |
WO2005017190A3 (en) | Mitotic kinesin inhibitors | |
WO2007011759A3 (en) | Inhibitors of mitotic kinesin | |
WO2005018547A3 (en) | Mitotic kinesin inhibitors | |
WO2006009975A3 (en) | Histamine to treat disorders affecting muscle function | |
WO2006078574A3 (en) | Mitotic kinesin inhibitors | |
WO2009009417A3 (en) | Pharmaceutical compositions and methods of preventing, treating, or inhibiting inflammatory diseases, disorders, or conditions of the skin, and diseases, disorders, or conditions associated with collagen depletion | |
DE602004016486D1 (en) | COMPOSITION FOR INHIBITING OR PREVENTING THE REDUCTION OF BONE DENSITY | |
WO2005082375A3 (en) | Treatment of interstitial cystitis with vitamin d compounds | |
WO2006053184A3 (en) | Methods for treating or preventing a vascular disease | |
WO2006007538A3 (en) | Composition and method for the treatment of asthma symptoms | |
HK1131340A1 (en) | Compositions comprising alpha-ketoglutarate and their use for modulating muscle performance | |
TW200607516A (en) | Anti-angiogenic compositions containing beeswax | |
WO2004060878A3 (en) | Inhibitors of phosphatases |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Annulment or lapse of patent due to non-payment of fees |